Filter posts

A Patient-Centric Approach to Investing & Partnering

Thursday’s Plenary Luncheon Fireside Chat at the 2018 BIO Investor Forum (BIF) featured two industry leaders: …

December 13 Webinar: Overview of JPM Week Receptions, Events, and Conferences

The annual J.P. Morgan Healthcare Conference week in San Francisco brings over 9,000 investors and …

17 Reasons to Attend #BIOWC17

The BIO World Congress on Industrial Biotechnology offers valuable opportunities for every budget. Here are …

Schedule JPM Meetings with BIO One-on-One Partnering™

BIO is taming the JPM “beast” by offering meeting space during JPM week, only accessible to …

Vote for Your Favorite Innovator - BIF’s Buzz of BIO Voting Now Open!

During the past week nominations were accepted for this year’s Buzz of BIO contest sponsored …

Life Science Leader Asks: What Areas Are Often Overlooked by Academics Turned Biotech Entrepreneurs?

In my third installment of a four-part series interviewing Peter Young, executive-in-residence with A.M. Pappas …

Partnering Trends in Latin America

If phonetics were the only driver, BRIC would be CRIB. But life sciences drug-related deal-making …

Protecting your IP Overseas

According to the World Intellectual Property Organization (WIPO), nearly 100,000 biotechnology and pharmaceutical patent applications …

FedEx’s Meet-and-Greet with Marshall Faulk during the BIO International Convention

We know that the BIO International Convention consists of a full agenda with a plethora …

What Do Large Pharma and Biotech Companies Want to Buy?

Out-licensors are always asking this fundamental question: what do in-licensors want? “In-licensors” extend far beyond …